Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 1 hour 2 min ago

European Commission Grants Orphan Drug Designation to Soliris(R) (eculizumab) for the Treatment of Patients with Myasthenia Gravis (MG)

Fri, 08/01/2014 - 14:16
CHESHIRE, Conn.--(Healthcare Sales & Marketing Network)--Alexion Pharmaceuticals (ALXN) today announced that the European Commission has granted orphan drug designation (ODD) to Soliris® (eculizumab) for the treatment of patients with Myasthenia Gravis...
Biopharmaceuticals, Regulatory
Alexion Pharmaceuticals, Soliris, eculizumab, Myasthenia Gravis

MEDICREA’s K-JAWS(R) Obtains FDA Approval for Its Marketing in the United States

Fri, 08/01/2014 - 13:49
LYON, France--(Healthcare Sales & Marketing Network)--The MEDICREA Group: (ALMED.PA) (FR0004178572-ALMED), which specializes in the development of innovative surgical technologies for the treatment of spinal pathologies and is listed on Alternext - Paris, ...
Devices, Neurosurgery, Orthopaedic, FDA
MEDICREA, K-JAWS, Cervical Compression Staple

American Shared Hospital Services Announces Proposed 2015 CMS Gamma Knife and Proton Therapy Reimbursement Rates

Thu, 07/31/2014 - 15:13
SAN FRANCISCO--(Healthcare Sales & Marketing Network)--AMERICAN SHARED HOSPITAL SERVICES (NYSE MKT:AMS), a leading provider of turnkey technology solutions for advanced radiosurgical and radiation therapy services, announced today that the Centers for Medi...
Devices, Oncology, Reimbursement
American Shared Hospital Services, Gamma Knife, proton therapy, radiotherapy

Intra-Cellular Therapies Announces the Appointment of Michael Halstead as Senior Vice President and General Counsel

Thu, 07/31/2014 - 15:07
NEW YORK, July 31, 2014 -- (Healthcare Sales & Marketing Network) -- Intra-Cellular Therapies, Inc. (ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced the appointment o...
Biopharmaceuticals, Neurology, Personnel
Intra-Cellular Therapies

Smith and Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market

Thu, 07/31/2014 - 13:02
LONDON, July 31, 2014 -- (Healthcare Sales & Marketing Network) -- Smith & Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced its entry into the forefoot market with the launch of the HAT-TRICK™ Lesser Toe Repair System. Co...
Devices, Orthopaedic, Product Launch
Smith & Nephew, HAT-TRICK, Lesser Toe Repair

K2M Continues Momentum with Complex Spine and Minimally Invasive Line Extensions and Regulatory Clearances

Thu, 07/31/2014 - 12:53
LEESBURG, Va., July 31, 2014 -- (Healthcare Sales & Marketing Network) -- K2M Group Holdings, Inc. (KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and prop...
Devices, Neurosurgery, Orthopaedic, FDA, Product Launch
K2M, CASPIAN, Occipital Anchor Spinal System, SERENGETI

Cynosure Appoints Chief Operating Officer and Chief Financial Officer Timothy W. Baker as President

Wed, 07/30/2014 - 16:03
WESTFORD, Mass., July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Cynosure, Inc. (CYNO), a leader in laser- and light-based aesthetic treatments for non-invasive and minimally invasive applications, today announced that the Board of Directors ha...
Devices, Dermatology, Personnel
Cynosure, laser

invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors

Wed, 07/30/2014 - 16:00
Key addition to board to strengthen invendo's U.S. footprint NEW YORK and KISSING, Germany, July 30, 2014 -- (Healthcare Sales & Marketing Network) -- invendo medical GmbH, manufacturer and distributor of a single use and computer-assisted ("robot...
Devices, Gastroenterology, Personnel
invendo medical, invendoscopy, endoscopy

Baxter Announces Divestiture of Commercial Vaccines Business to Pfizer

Wed, 07/30/2014 - 15:56
DEERFIELD, Ill.--(Healthcare Sales & Marketing Network)--Baxter International Inc. (BAX) today announced that it has entered into a definitive agreement to sell its two commercially marketed vaccines and related production facilities to Pfizer Inc. for a t...
Biopharmaceuticals, Acquisitions
Baxter International, Pfizer, NeisVac-C, FSME-IMMUN, vaccine

Celldex Therapeutics Announces Senior Leadership Promotions

Wed, 07/30/2014 - 15:53
HAMPTON, N.J., July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Celldex Therapeutics, Inc. (CLDX) today announced three promotions in the Company's clinical and research departments: Tibor Keler, PhD promoted to Executive Vice President and Ch...
Biopharmaceuticals, Personnel
Celldex Therapeutics

Study Shows that RapidArc(R) Radiosurgery Substantially More Efficient and Comparable in Quality to Gamma Knife(R) in the Treatment of Multiple Brain Metastases

Wed, 07/30/2014 - 13:33
Article in "Neurosurgery" describes how RapidArc Radiosurgery treatments can be specially optimized to treat multiple brain metastases at the same time Company Also Appoints Carolina Alarco to President, International and Johanna Sealscott to ...
Devices, Oncology
Varian Medical Systems, RapidArc, Radiosurgery, Gamma Knife, radiotherapy

Aegerion Pharmaceuticals Appoints Craig Fraser as Chief Operating Officer

Wed, 07/30/2014 - 13:26
CAMBRIDGE, Mass., July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Aegerion Pharmaceuticals, Inc. (AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare d...
Biopharmaceuticals, Personnel
Aegerion Pharmaceuticals

Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors

Wed, 07/30/2014 - 13:20
SAN DIEGO, July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Epic Sciences, Inc. ("Epic"), a private biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announce...
Diagnostics, Personalized Medicine, Personnel
Epic Sciences, Circulating Tumor Cells

Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine

Wed, 07/30/2014 - 13:11
Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 -- (Healthcare Sales & Marketing Network) -- Epic Sciences, Inc. ("Epic&...
Diagnostics, Personalized Medicine, Venture Capital
Epic Sciences, Circulating Tumor Cells

AMNIOX(R) Medical Announces Initiation of Prospective, Randomized, Controlled Clinical Study of Chronic Wounds

Tue, 07/29/2014 - 15:41
Study aims to demonstrate a clinically effective and cost-efficient option for patients with hard-to-heal diabetic wounds ATLANTA--(Healthcare Sales & Marketing Network)--Amniox Medical, Inc., a developer and marketer of restorative therapies processed ...
Regenerative Medicine, Wound Care
Amniox Medical, amniotic membrane, umbilical cord, diabetic foot ulcer

Abide Therapeutics Appoints Nancy Thornberry to Board of Directors

Tue, 07/29/2014 - 15:37
SAN DIEGO, July 29, 2014 -- (Healthcare Sales & Marketing Network) -- Abide Therapeutics announced today the appointment of Nancy Thornberry to its board of directors. Thornberry was previously senior vice president and franchise head, Diabetes and Endocr...
Biopharmaceuticals, Personnel
Abide Therapeutics, Serine Hydrolase

Teleflex Receives FDA Clearance for 150 cm Length Arrow(R) GPSCath(R) Balloon Dilatation Catheters

Tue, 07/29/2014 - 15:16
PTA balloon catheters combine angioplasty with targeted injection system in a single device for use in below the knee procedures WAYNE, Pa.--(Healthcare Sales & Marketing Network)--Teleflex Incorporated (TFX), a leading global provider of medical device...
Devices, Interventional, FDA
Teleflex, Arrow, GPSCath, Balloon Catheter, angioplasty

Intellijoint(TM) Wins FDA Clearance of New Instrument for Improving Hip Surgery

Tue, 07/29/2014 - 15:13
WATERLOO, ONTARIO--(Healthcare Sales & Marketing Network) - Intellijoint Surgical Inc. (formerly, Avenir Medical), innovator in developing smart tools to improve joint replacement surgery, announced today that it has obtained clearance from the US Food and...
Devices, Orthopaedic, FDA
Intellijoint Surgical, Avenir Medical, Intellijoint HIP

Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer

Tue, 07/29/2014 - 15:10
OXFORD, England, July 29, 2014 -- (Healthcare Sales & Marketing Network) --Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FS...
Biopharmaceuticals, Diagnostics, Oncology, Licensing
Glide Pharma, FScan, prostate cancer

Owens and Minor Implements Management Succession Plan

Tue, 07/29/2014 - 15:06
President & COO James Bierman Named President & CEO, Effective September 1st; Craig Smith to Serve as Executive Chairman RICHMOND, Va.--(Healthcare Sales & Marketing Network)--Owens & Minor, Inc. (OMI), a leading healthcare logistics company, today ann...
Devices, Distribution, Personnel
Owens & Minor

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong